{
  "patient_information": "Age: 44 years Sex: male Comorbidities: [\"type 2 diabetes\"] Immunosuppression: non-adherent to antidiabetic medication",
  "chief_complaint": "Prolonged fever, jaundice, back abscess and chest signs",
  "history_of_present_illness": "1-month history of fever, headache, generalized myalgia and arthralgia with a painful swelling over the left scapula. The swelling has gradually increased in size without any history of preceding trauma.",
  "exposure_and_epidemiology": "Travel history: Presented during the rainy season Vector exposures: No reported mosquito or tick exposure Animal exposures: No animal exposures reported Water food risks: No water/food risks reported Contacts: No sick contacts reported Season outbreak context: Presented during the rainy season",
  "vitals": "Temperature: 40°C (104°F) Heart rate: 136 bpm Blood pressure: 140/80 mmHg Respiratory rate: 30 breaths per minute Oxygen saturation: 92% Icterus: Present",
  "physical_exam": "General appearance: Severely ill, pale and jaundiced Skin exam: Hypopigmented macular skin lesions consistent with pityriasis versicolor Head and neck exam: No focal neurologic deficits or respiratory distress described Chest exam: Bilateral crepitations and reduced breath sounds at both lung bases Abdominal exam: Soft abdomen, no palpable organomegaly",
  "labs_and_diagnostics": "Cbc: {\"WBC\": \"16.2 × 10^9/L\", \"Polymorphs\": \"92.1%\", \"Hemoglobin\": \"12.5 g/dL\", \"Platelets\": \"112 × 10^9/L\"} Biochemistry: {\"Glucose\": \"20.6 mmol/L\", \"Creatinine\": \"56 μmol/L\", \"Urea\": \"6.8 mmol/L\", \"AST\": \"131 U/L\", \"ALT\": \"83 U/L\", \"Total_bilirubin\": \"111.2 μmol/L\", \"Direct_bilirubin\": \"56.4 μmol/L\"} Microbiology: {\"Blood_culture\": \"Bacillus pseudomallei\", \"Throat_swab\": \"Negative for M. tuberculosis-PCR\", \"CXR\": \"Bilateral pleural effusions\"}",
  "differential_diagnosis": "['Bacterial abscess with sepsis (Staphylococcus aureus, Streptococcus pyogenes)', 'Melioidosis (Burkholderia pseudomallei)', 'Tuberculosis', 'Disseminated fungal infection']",
  "management_and_clinical_course": "{'Initial_treatment': 'Empirically treated with ceftriaxone and gentamicin', 'Switch_to_ceftazidime': 'After 48 hours when the laboratory alerted clinicians to suspicion of melioidosis', 'Clinical_improvement': 'Improved after 7 days of treatment, afebrile by day 14', 'Oral_co-trimoxazole': 'Switched to oral co-trimoxazole for 20 weeks', 'Glycaemic_control': 'Established', 'Outcome': \"Discharged after 21 days of hospitalization and continued on oral 'eradication' treatment for 5 months\"}",
  "final_diagnosis": "Disease name short: Melioidosis Confirmation method: Positive blood culture for Bacillus pseudomallei Evidence: Clinical presentation, laboratory findings (positive blood culture), and response to therapy with ceftazidime",
  "disease_name_short": null
}